Story

IK flies high with sale of Dutch drugs company

IK Investment Partners has agreed to sell a Dutch business that produces over-the-counter drugs and food supplements to an entity owned by Charterhouse Capital Partners.

IK Investment Partners has agreed to sell a Dutch business that produces over-the-counter drugs and food supplements to an entity owned by Charterhouse Capital Partners.

Financial details of the sale of Vemedia were undisclosed in the statement on July 28, but a person familiar with the matter said that the enterprise value was approximately €375 million, with the sale netting IK a return of 2.4x, the person added.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump